Clinical Trials
139 trialsRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
University of Southern California
ANTARES
Instituto do Cancer do Estado de São Paulo
TRAP-BTC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
City of Hope Medical Center
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Case Comprehensive Cancer Center
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
University of Michigan Rogel Cancer Center
Target-specific immunoPET Imaging of Digestive System Carcinoma
RenJi Hospital
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
Yonsei University
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
University of Southern California
DETERMINE
Cancer Research UK
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
City of Hope Medical Center
STALL
Helsinki University Central Hospital
ROBOCOP
Karolinska University Hospital
SAIB
First Affiliated Hospital of Zhejiang University
HPB70+
Assistance Publique - Hôpitaux de Paris
GALENT-BT
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
NEOGB
Rajiv Gandhi Cancer Institute & Research Center, India
RUGB
Tata Memorial Centre
ACTICCA-1
Universitätsklinikum Hamburg-Eppendorf
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
GOLD-HAIC
Tianjin Medical University Cancer Institute and Hospital
DEBATE
Asan Medical Center
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
LIVELONG
University of California, Davis
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab
Ohio State University Comprehensive Cancer Center
CaSSY
University of Pittsburgh
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
M.D. Anderson Cancer Center
TESLA RCT
Erasmus Medical Center
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Shanghai Jiao Tong University School of Medicine
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Banaras Hindu University
GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers
University of California, San Diego
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
Saint Vincent's Hospital, Korea
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
University of Nebraska
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
Yonsei University
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ASPIRE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
Eastern Hepatobiliary Surgery Hospital
ADBoard
Charite University, Berlin, Germany
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer
Mayo Clinic
TAS-102 in Treating Advanced Biliary Tract Cancers
Mayo Clinic
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
IMMUCHEC
AIO-Studien-gGmbH